{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:09:31Z","timestamp":1789459771495,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Among the total reported cases of pancreatic duct adenocarcinomas, around 1\u20132.9% are adenosquamous carcinomas of the pancreas. Due to limited data, preoperative diagnosis is a great challenge for physicians, and it is usually set post-operational, based on the pathologist report. We operated on two cases of adenosquamous carcinoma of the pancreas, which we present alongside the operation and treatment planning.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case report<\/jats:title>\n                <jats:p>A 69-year-old Caucasian female and a 63-year-old Caucasian male presented themselves with jaundice in our department. The abdomen computed tomography and magnetic resonance imaging scans revealed lesions of the pancreas. A pancreas\u2013duodenumectomy was performed in both patients, and the post-operational histology analysis revealed adenosquamous carcinoma of the pancreas head. The patients were discharged in good condition and received further chemotherapy treatment after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Two case reports of adenosquamous carcinoma of the pancreas are described here, which both underwent surgery resection. The limited available literature on this topic substantially limits the knowledge and guidance on treatment. A summarization of the available literature is attempted, alongside a description of possible fields of future research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03610-5","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:03:54Z","timestamp":1667088234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adenosquamous carcinoma of the pancreas: two case reports and review of the literature\u00a0"],"prefix":"10.1186","volume":"16","author":[{"given":"Daniel","family":"Paramythiotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-7527","authenticated-orcid":false,"given":"Filippos","family":"Kyriakidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Karlafti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triantafyllos","family":"Didangelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias-Marios","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anestis","family":"Karakatsanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Poulios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Chamalidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Vagionas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Michalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,30]]},"reference":[{"key":"3610_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jss.2011.06.015","volume":"174","author":"CA Boyd","year":"2012","unstructured":"Boyd CA, Benarroch-Gampel J, Sheffield KM, Cooksley CD, Riall TS. 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. J Surg Res. 2012;174:12\u20139. https:\/\/doi.org\/10.1016\/j.jss.2011.06.015.","journal-title":"J Surg Res"},{"key":"3610_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4251\/wjgo.v7.i9.132","volume":"7","author":"E Borazanci","year":"2015","unstructured":"Borazanci E, Millis SZ, Korn R, Han H, Whatcott CJ, Gatalica Z, et al. Adenosquamous carcinoma of the pancreas: molecular characterization of 23 patients along with a literature review. World J Gastrointest Oncol. 2015;7:132\u201340. https:\/\/doi.org\/10.4251\/wjgo.v7.i9.132.","journal-title":"World J Gastrointest Oncol"},{"key":"3610_CR3","first-page":"75","volume":"6","author":"CG Simone","year":"2013","unstructured":"Simone CG, Zuluaga Toro T, Chan E, Feely MM, Trevino JG, George TJ. Characteristics and outcomes of adenosquamous carcinoma of the pancreas. Gastrointest Cancer Res. 2013;6:75\u20139.","journal-title":"Gastrointest Cancer Res"},{"key":"3610_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4251\/wjgo.v9.i9.390","volume":"9","author":"FM de Juan","year":"2017","unstructured":"de Juan FM, Escribano MR, Lapiedra CM, de Alcantara FM, Soto MC, Fons AC, et al. Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier. World J Gastrointest Oncol. 2017;9:390. https:\/\/doi.org\/10.4251\/wjgo.v9.i9.390.","journal-title":"World J Gastrointest Oncol"},{"key":"3610_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/modpathol.3880332","volume":"14","author":"DE Kardon","year":"2001","unstructured":"Kardon DE, Thompson LD, Przygodzki RM, Heffess CS. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Mod Pathol. 2001;14:443\u201351. https:\/\/doi.org\/10.1038\/modpathol.3880332.","journal-title":"Mod Pathol"},{"key":"3610_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/modpathol.2009.15","volume":"22","author":"JR Brody","year":"2009","unstructured":"Brody JR, Costantino CL, Potoczek M, Cozzitorto J, McCue P, Yeo CJ, et al. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma. Mod Pathol. 2009;22:651\u20139. https:\/\/doi.org\/10.1038\/modpathol.2009.15.","journal-title":"Mod Pathol"},{"key":"3610_CR7","doi-asserted-by":"publisher","first-page":"e15229","DOI":"10.1200\/jco.2014.32.15_suppl.e15229","volume":"32","author":"E Borazanci","year":"2014","unstructured":"Borazanci E, Millis SZ, Winkler J, Ramanathan RK, Von Hoff DD. Multiplatform profiling of rare pancreatic carcinoma subtypes to identify potential actionable targets. J Clin Oncol. 2014;32:e15229\u2013e15229. https:\/\/doi.org\/10.1200\/jco.2014.32.15_suppl.e15229.","journal-title":"J Clin Oncol"},{"key":"3610_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/MPA.0b013e3181d788ca","volume":"39","author":"Y Okamura","year":"2010","unstructured":"Okamura Y, Sugimoto H, Fujii T, Nomoto S, Takeda S, Nakao A. Adenosquamous carcinoma arising in an intraductal pa-pillary mucinous neoplasm of the pancreas. Pancreas. 2010;39:945\u20137. https:\/\/doi.org\/10.1097\/MPA.0b013e3181d788ca.","journal-title":"Pancreas"},{"key":"3610_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/MPA.0000000000000556","volume":"45","author":"S Matsuzaka","year":"2016","unstructured":"Matsuzaka S, Karasaki H, Ono Y, Ogata M, Oikawa K, Tamakawa S, et al. Tracking the clonal evolution of adenosquamous carcinoma, a rare variant of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 2016;45:915\u20138. https:\/\/doi.org\/10.1097\/MPA.0000000000000556.","journal-title":"Pancreas"},{"key":"3610_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/ajcp\/77.2.137","volume":"77","author":"PM Pour","year":"1982","unstructured":"Pour PM, Sayed S, Sayed G. Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol. 1982;77:137\u201352. https:\/\/doi.org\/10.1093\/ajcp\/77.2.137.","journal-title":"Am J Clin Pathol"},{"key":"3610_CR11","first-page":"528","volume":"45","author":"B Cylwik","year":"1998","unstructured":"Cylwik B, Nowak HF, Puchalski Z, Barczyk J. Epithelial anomalies in chronic pancreatitis as a risk factor of pancreatic cancer. Hepatogastroenterology. 1998;45:528\u201332.","journal-title":"Hepatogastroenterology"},{"key":"3610_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/dc.1099","volume":"25","author":"LJ Layfield","year":"2001","unstructured":"Layfield LJ, Cramer H, Madden J, Gopez EV, Liu K. Atypical squamous epithelium in cytologic specimens from the pancreas: cytological differential diagnosis and clinical implications. Diagn Cytopathol. 2001;25:38\u201342. https:\/\/doi.org\/10.1002\/dc.1099.","journal-title":"Diagn Cytopathol"},{"key":"3610_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.crad.2014.03.014","volume":"69","author":"T Kubo","year":"2014","unstructured":"Kubo T, Takeshita T, Shimono T, Hashimoto S, Miki Y. Squamous-lined cyst of the pancreas: radiological\u2013pathological correlation. Clin Radiol. 2014;69:880\u20136. https:\/\/doi.org\/10.1016\/j.crad.2014.03.014.","journal-title":"Clin Radiol"},{"key":"3610_CR14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/SMJ.0b013e3181ebadbd","volume":"103","author":"G Trikudanathan","year":"2010","unstructured":"Trikudanathan G, Dasanu CA. Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity. South Med J. 2010;103:903\u201310. https:\/\/doi.org\/10.1097\/SMJ.0b013e3181ebadbd.","journal-title":"South Med J"},{"key":"3610_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/archsurg.134.6.599","volume":"134","author":"JA Madura","year":"1999","unstructured":"Madura JA, Jarman BT, Doherty MG, Yum MN, Howard TJ. Adenosquamous carcinoma of the pancreas. Arch Surg. 1999;134:599\u2013603. https:\/\/doi.org\/10.1001\/archsurg.134.6.599.","journal-title":"Arch Surg"},{"key":"3610_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/01913128209016621","volume":"3","author":"J Kovi","year":"1982","unstructured":"Kovi J. Adenosquamous carcinoma of the pancreas: a light and electron microscopic study. Ultrastruct Pathol. 1982;3:17\u201323. https:\/\/doi.org\/10.3109\/01913128209016621.","journal-title":"Ultrastruct Pathol"},{"key":"3610_CR17","doi-asserted-by":"publisher","first-page":"95773","DOI":"10.18632\/oncotarget.21319","volume":"8","author":"N Silvestris","year":"2017","unstructured":"Silvestris N, Danza K, Longo V, Brunetti O, Fucci L, Argentiero A, et al. Angiogenesis in adenosquamous cancer of pancreas. Oncotarget. 2017;8:95773\u20139. https:\/\/doi.org\/10.18632\/oncotarget.21319.","journal-title":"Oncotarget"},{"key":"3610_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/pros.20163","volume":"62","author":"A Json Lind","year":"2005","unstructured":"Json Lind A, Wikstr\u00f6m P, Granfors T, Egevad L, Stattin P, Bergh A. Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer. Prostate. 2005;62:394\u20139. https:\/\/doi.org\/10.1002\/pros.20163.","journal-title":"Prostate"},{"key":"3610_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ijc.10851","volume":"103","author":"C Sfiligoi","year":"2003","unstructured":"Sfiligoi C, de Luca A, Cascone I, Sorbello V, Fuso L, Ponzone R, et al. Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer. 2003;103:466\u201374. https:\/\/doi.org\/10.1002\/ijc.10851.","journal-title":"Int J Cancer"},{"key":"3610_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/RCT.0b013e31827bc452","volume":"37","author":"Q Yin","year":"2013","unstructured":"Yin Q, Wang C, Wu Z, Wang M, Cheng K, Zhao X, et al. Adenosquamous carcinoma of the pancreas: multidetector-row computed tomographic manifestations and tumor characteristics. J Comput Assist Tomogr. 2013;37:125\u201333. https:\/\/doi.org\/10.1097\/RCT.0b013e31827bc452.","journal-title":"J Comput Assist Tomogr"},{"key":"3610_CR21","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/ijms17060834","volume":"17","author":"X Guo","year":"2016","unstructured":"Guo X, Zhai L, Xue R, Shi J, Zeng Q, Gao C. Mast cell tryptase contributes to pancreatic cancer growth through promoting angiogenesis via activation of angiopoietin-1. Int J Mol Sci. 2016;17:834. https:\/\/doi.org\/10.3390\/ijms17060834.","journal-title":"Int J Mol Sci"},{"key":"3610_CR22","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1053\/j.gastro.2010.08.012","volume":"139","author":"S Grover","year":"2010","unstructured":"Grover S, Syngal S. Hereditary pancreatic cancer. Gastroenterology. 2010;139:1076-1080.e2. https:\/\/doi.org\/10.1053\/j.gastro.2010.08.012.","journal-title":"Gastroenterology"},{"key":"3610_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12885-020-6516-1","volume":"20","author":"CM Connell","year":"2020","unstructured":"Connell CM, Brais R, Whitaker H, Upponi S, Beh I, Risdall J, et al. Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case report. BMC Cancer. 2020;20:38. https:\/\/doi.org\/10.1186\/s12885-020-6516-1.","journal-title":"BMC Cancer"},{"key":"3610_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1200\/JCO.1991.9.3.491","volume":"9","author":"JL Abbruzzese","year":"1991","unstructured":"Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, et al. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol. 1991;9:491\u20138. https:\/\/doi.org\/10.1200\/JCO.1991.9.3.491.","journal-title":"J Clin Oncol"},{"key":"3610_CR25","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0959-8049(98)00058-6","volume":"34","author":"M Miwa","year":"1998","unstructured":"Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer. 1998;34:1274\u201381. https:\/\/doi.org\/10.1016\/S0959-8049(98)00058-6.","journal-title":"Eur J Cancer"},{"key":"3610_CR26","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2217\/pgs.13.93","volume":"14","author":"C Serdjebi","year":"2013","unstructured":"Serdjebi C, Seitz J-F, Ciccolini J, Duluc M, Norguet E, Fina F, et al. Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen. Pharmacogenomics. 2013;14:1047\u201351. https:\/\/doi.org\/10.2217\/pgs.13.93.","journal-title":"Pharmacogenomics"},{"key":"3610_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.bjc.6602673","volume":"93","author":"C Bengala","year":"2005","unstructured":"Bengala C, Guarneri V, Giovannetti E, Lencioni M, Fontana E, Mey V, et al. Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma. Br J Cancer. 2005;93:35\u201340. https:\/\/doi.org\/10.1038\/sj.bjc.6602673.","journal-title":"Br J Cancer"},{"key":"3610_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135907","volume":"10","author":"C Serdjebi","year":"2015","unstructured":"Serdjebi C, Gagni\u00e8re J, Desram\u00e9 J, Fein F, Guimbaud R, Fran\u00e7ois E, et al. FFCD-1004 clinical trial: impact of cytidine deaminase activity on clinical outcome in gemcitabine-monotherapy treated patients. PLoS ONE. 2015;10: e0135907. https:\/\/doi.org\/10.1371\/journal.pone.0135907.","journal-title":"PLoS ONE"},{"key":"3610_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1158\/2159-8290.CD-11-0242","volume":"2","author":"KK Frese","year":"2012","unstructured":"Frese KK, Neesse A, Cook N, Bapiro TE, Lolkema MP, Jodrell DI, et al. nab-paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. Cancer Discov. 2012;2:260\u20139. https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0242.","journal-title":"Cancer Discov"},{"key":"3610_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000074480","volume":"65","author":"T Morita","year":"2003","unstructured":"Morita T, Matsuzaki A, Kurokawa S, Tokue A. Forced expression of cytidine deaminase confers sensitivity to capecita-bine. Oncology. 2003;65:267\u201374. https:\/\/doi.org\/10.1159\/000074480.","journal-title":"Oncology"},{"key":"3610_CR31","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/cas.12501","volume":"105","author":"T Okusaka","year":"2014","unstructured":"Okusaka T, Ikeda M, Fukutomi A, Ioka T, Furuse J, Ohkawa S, et al. Phase II study of FOLFIRINOX for chemotherapy-na\u00efve Japanese patients with metastatic pancreatic cancer. Cancer Sci. 2014;105:1321\u20136. https:\/\/doi.org\/10.1111\/cas.12501.","journal-title":"Cancer Sci"},{"key":"3610_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00261-015-0616-4","volume":"41","author":"F Toshima","year":"2016","unstructured":"Toshima F, Inoue D, Yoshida K, Yoneda N, Minami T, Kobayashi S, et al. Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with pathologic correlations and comparison with adenocarcinoma of pancreas. Abdom Radiol. 2016;41:508\u201320. https:\/\/doi.org\/10.1007\/s00261-015-0616-4.","journal-title":"Abdom Radiol"},{"key":"3610_CR33","first-page":"370","volume":"37","author":"DTH De Moura","year":"2017","unstructured":"De Moura DTH, Coronel M, Chacon DA, Tanigawa R, Chaves DM, Matuguma SE, et al. Primary adenosquamous cell carcinoma of the pancreas: the use of endoscopic ultrasound guided\u2014fine needle aspiration to establish a definitive cyto-logic diagnosis. Rev Gastroenterol Del Peru Organo La Soc Gastroenterol Del Peru. 2017;37:370\u20133.","journal-title":"Rev Gastroenterol Del Peru Organo La Soc Gastroenterol Del Peru"},{"key":"3610_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/dc.23116","volume":"42","author":"DS Strand","year":"2014","unstructured":"Strand DS, Jeffus SK, Sauer BG, Wang AY, Stelow EB, Shami VM. EUS-guided 22-gauge fine-needle aspiration versus core biopsy needle in the evaluation of solid pancreatic neoplasms. Diagn Cytopathol. 2014;42:751\u20138. https:\/\/doi.org\/10.1002\/dc.23116.","journal-title":"Diagn Cytopathol"},{"key":"3610_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","volume":"62","author":"MI Canto","year":"2013","unstructured":"Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley J-W, Kamel I, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62:339\u201347. https:\/\/doi.org\/10.1136\/gutjnl-2012-303108.","journal-title":"Gut"},{"key":"3610_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG Clinical Guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223\u201362. https:\/\/doi.org\/10.1038\/ajg.2014.435.","journal-title":"Am J Gastroenterol"},{"key":"3610_CR37","unstructured":"Pancreatic Cancer UK n.d. https:\/\/www.pancreaticcancer.org.uk."},{"key":"3610_CR38","doi-asserted-by":"publisher","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","volume":"26","author":"M Ducreux","year":"2015","unstructured":"Ducreux M, Cuhna AS, Caramella C, Hollebecque A, Burtin P, Go\u00e9r\u00e9 D, et al. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:v56-68. https:\/\/doi.org\/10.1093\/annonc\/mdv295.","journal-title":"Ann Oncol"},{"key":"3610_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10147-007-0690-x","volume":"13","author":"K Shibagaki","year":"2008","unstructured":"Shibagaki K, Fujita K, Nakayama S, Takenaka M, Fukuba N, Matsui S, et al. Complete response of a pancreatic adenosquamous carcinoma to chemoradiotherapy. Int J Clin Oncol. 2008;13:74\u20137. https:\/\/doi.org\/10.1007\/s10147-007-0690-x.","journal-title":"Int J Clin Oncol"},{"key":"3610_CR40","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1200\/JCO.2016.67.5553","volume":"34","author":"AA Khorana","year":"2016","unstructured":"Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, et al. Potentially curable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34:2541\u201356. https:\/\/doi.org\/10.1200\/JCO.2016.67.5553.","journal-title":"J Clin Oncol"},{"key":"3610_CR41","doi-asserted-by":"publisher","first-page":"117955491988658","DOI":"10.1177\/1179554919886587","volume":"13","author":"H Del Arco","year":"2019","unstructured":"Del Arco H, Chakiba-Brug\u00e8re C, Salabert L, B\u00e9chade D. Adenosquamous carcinoma of the pancreas. Clin Med Insights Oncol. 2019;13:117955491988658. https:\/\/doi.org\/10.1177\/1179554919886587.","journal-title":"Clin Med Insights Oncol"},{"key":"3610_CR42","doi-asserted-by":"publisher","first-page":"111346","DOI":"10.18632\/oncotarget.22795","volume":"8","author":"K Yoshida","year":"2017","unstructured":"Yoshida K, Iwashita T, Uemura S, Maruta A, Okuno M, Ando N, et al. A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer. Oncotarget. 2017;8:111346\u201355. https:\/\/doi.org\/10.18632\/oncotarget.22795.","journal-title":"Oncotarget"},{"key":"3610_CR43","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","volume":"389","author":"JP Neoptolemos","year":"2017","unstructured":"Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389:1011\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(16)32409-6.","journal-title":"Lancet"},{"key":"3610_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3978\/j.issn.2078-6891.2014.091","volume":"6","author":"AT Wild","year":"2015","unstructured":"Wild AT, Dholakia AS, Fan KY, Kumar R, Moningi S, Rosati LM, et al. Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas. J Gastrointest Oncol. 2015;6:115\u201325. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2014.091.","journal-title":"J Gastrointest Oncol"},{"key":"3610_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.6092\/1590-8577\/2358","volume":"15","author":"AL De Souza","year":"2014","unstructured":"De Souza AL, Saif MW. Platinum-based therapy in adenosquamous pancreatic cancer: experience at two institutions. JOP. 2014;15:144\u20136. https:\/\/doi.org\/10.6092\/1590-8577\/2358.","journal-title":"JOP"},{"key":"3610_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1089\/crpc.2015.29003.vye","volume":"1","author":"V Yeung","year":"2015","unstructured":"Yeung V, Palmer JD, Williams N, Weinstein JC, Fortuna D, Sama A, et al. Adenosquamous carcinoma of the pancreas in a patient with BRCA2 mutation: a case report. Case Reports Pancreat Cancer. 2015;1:22\u20135. https:\/\/doi.org\/10.1089\/crpc.2015.29003.vye.","journal-title":"Case Reports Pancreat Cancer"},{"key":"3610_CR47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.21037\/atm.2019.10.12","volume":"7","author":"Y Fang","year":"2019","unstructured":"Fang Y, Pu N, Zhang L, Wu W, Lou W. Chemoradiotherapy is associated with improved survival for resected pancreatic adenosquamous carcinoma: a retrospective cohort study from the SEER database. Ann Transl Med. 2019;7:522\u2013522. https:\/\/doi.org\/10.21037\/atm.2019.10.12.","journal-title":"Ann Transl Med"},{"key":"3610_CR48","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/cam4.2851","volume":"9","author":"JD Gruhl","year":"2020","unstructured":"Gruhl JD, Garrido-Laguna I, Francis SR, Affolter K, Tao R, Lloyd S. The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer. Cancer Med. 2020;9:1703\u201311. https:\/\/doi.org\/10.1002\/cam4.2851.","journal-title":"Cancer Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03610-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:04:28Z","timestamp":1667088268000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03610-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3610"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03610-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,30]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"395"}}